Evaluating a New HPV Test
This study is looking at a new way to test for Human Papillomavirus (HPV), called the "Rice HPV test." HPV is a common virus that can cause certain cancers, like cervical cancer. Researchers want to see if this new test works as well as the standard HPV tests currently used. The goal is to develop HPV tests that are easier to use and more widely available. You may be able to join if you are a woman with a cervix, aged 21 or older, and are already scheduled for an HPV test or certain cervical procedures at MD Anderson or The Harris Health System (LBJ Hospital). The study aims to enroll 600 participants, but its current status is unclear.
- Study design
- This is an observational study, meaning researchers will observe and collect information without assigning specific treatments. It plans to enroll 600 women.
- What's involved
- You would undergo the "Rice HPV test" and potentially have your results compared with other tests and pathology results. The study will last an average of one year.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed through study completion, which is an average of one year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kathleen Schmeler, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Novel point-of-care diagnostic test for detecting HPV ("Rice HPV test")Through study completion; an average of 1 year
To evaluate the performance of the 3 version of a novel point-of-care diagnostic test for detecting HPV ("Rice HPV test").